Xylocaine
DrugFirst group were given xylocaine
Other names: X
NCT Number: NCT02682134
The aim of this interventional study is to find out the incidence of sore throat among intubated patients in Jordan university hospital and to find out which is preventive and effective method to decrease sore throat;is it xylocaine gel on endotracheal cuff as lubricant versus dexamethasone 8 mg intravenously or both.
Looking for future studies?
Notify Me15 year–70 year
All sexes
Interventional
Phase 4
Three groups were divided into: first group received xylocaine gel as endotracheal cuff lubricant,second group received dexamethasone 8 mg intravenously and third group received both( xylocaine and dexamethasone).
The investigator compared between the three groups regarding sore throat in intubated patients and followed them up to 48 hours.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
First group were given xylocaine
Other names: X
Second group were given Dexamethasone
Other names: D
Third group were given both Xylocaine and Dexamethasone
Other names: XD
Time frame: 4 months
Questionnaire follow up in intubated patients.
Time frame: 4 months
Sore throat scale from None,mild,moderate till severe.
University of Jordan
Other
Comparison Between Xylocaine Gel as Endotracheal Cuff Lubricant Versus Dexamethasone 8 mg Intravenously or Both for Sore Throat Prevention Following Intubation: Interventional Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06677567
Infections, Otorhinolaryngologic Diseases
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT07486544
Infections, Otorhinolaryngologic Diseases
Asyut, Egypt
View Trial DetailsNCT06939842
Infections, Intervertebral disc disease
Istanbul, Turkey, Turkey (Türkiye)
View Trial DetailsNCT07202624
Infections, Otorhinolaryngologic Diseases
Riyadh, Saudi Arabia
View Trial Details